FDBK.LSE Feedback PLC
- Market cap
- GBX 2.26M
- P/E
- -
- P/B
- 0.51x
- ROE
- -156.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Nov 2025.
Is FDBK.LSE undervalued?
Graham numberThe Graham number of Feedback PLC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Feedback PLC fundamental analysis
No fundamental analysis for Feedback PLC yet.
Feedback PLC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Feedback PLC
Feedback plc provides software and systems to those working in the field of medical imaging. The company's products include Bleepa, an image-based communication platform for frontline clinicians; CareLocker, a patient-centric cloud architecture; and Feedback Connect that enables imaging-led point-of-care decision making in remote areas. The company was incorporated in 1958 and is based in London, the United Kingdom.
Full company profileFeedback PLC financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 1 quarter up to Nov 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Feedback PLC annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 431K | 466K | 458K | 563K | 450K | 287K | 589K | 1.02M | 1.18M | 886K | 1.65M |
| Gross Profit | 424K | 455K | 442K | 558K | 418K | 214K | -63.7K | 131K | 1.10M | 779K | 628K |
| Operating Income | -253K | -301K | -748K | -1.09M | -1.40M | -2.06M | -2.51M | -3.42M | -3.69M | -4.21M | -7.52M |
| EBITDA | -207K | -253K | -691K | -1.03M | -1.38M | -2.01M | -1.96M | -2.61M | -2.73M | -3.06M | -6.80M |
| Net Income | -183K | -266K | -631K | -973K | -1.09M | -1.62M | -2.12M | -2.92M | -3.30M | -7.32M | -6.97M |
| EPS | -0.18 | -0.23 | -0.50 | -0.57 | -0.43 | -0.31 | -0.23 | -0.22 | -0.25 | -0.25 | -0.16 |
| Balance Sheet | |||||||||||
| Total Assets | 326K | 893K | 1.06M | 1.49M | 2.50M | 5.82M | 14.3M | 11.7M | 8.34M | 6.75M | 4.86M |
| Total Liabilities | 196K | 324K | 690K | 544K | 729K | 553K | 594K | 855K | 694K | 589K | 400K |
| Shareholders' Equity | 130K | 569K | 365K | 946K | 1.77M | 5.27M | 13.7M | 10.9M | 7.64M | 6.16M | 4.46M |
| Cash & Short-term Investments | 106K | 697K | 632K | 541K | 733K | 2.22M | 10.3M | 7.32M | 3.88M | 5.95M | 3.82M |
| Total Debt | 189K | - | - | - | - | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -205K | -90.6K | -358K | -983K | -786K | -2.03M | -1.25M | -1.74M | -2.22M | -2.82M | -7.19M |
| Capital Expenditure | 104.00 | 2.94K | 6.25K | 3.42K | 883K | 1.44M | 1.15M | 1.24M | 12.5K | 10.5K | 12.0K |
| Free Cash Flow | -205K | -93.5K | -364K | -987K | -1.67M | -3.47M | -2.41M | -2.99M | -2.14M | -2.83M | -7.20M |
| Ratios | |||||||||||
| ROE | -141.2% | -46.7% | -172.7% | -102.9% | -61.5% | -30.7% | -15.5% | -26.8% | -43.1% | -118.7% | -156.2% |
| ROA | -56.2% | -29.8% | -59.8% | -65.3% | -43.5% | -27.8% | -14.8% | -24.9% | -39.6% | -108.3% | -143.3% |
| Net Profit Margin | -42.5% | -57.1% | -137.6% | -172.8% | -241.7% | -563.5% | -360.0% | -284.7% | -279.2% | -826.2% | -421.8% |
| Debt to Equity | 1.46x | - | - | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Feedback PLC dividends
Feedback PLC has not paid dividends in the last 9 fiscal years.
Last stock split: 1:200 on Oct 14, 2022.
Who owns Feedback PLC
- Insiders 6.38%
- Institutions 48.94%
- Public & others 44.69%
- Shares outstanding 43.8M
- Free float 33.0M
Feedback PLC company profile
- Company name
- Feedback PLC
- Ticker
- FDBK.LSE
- ISIN
- GB0003340550
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 29
- Fiscal year end
- May
- Address
- 201 Temple Chambers, London, United Kingdom, EC4Y 0DT
- Phone
- 44 20 3997 7634
- Website
- feedbackmedical.com
About Feedback PLC
Feedback plc provides software and systems to those working in the field of medical imaging. The company's products include Bleepa, an image-based communication platform for frontline clinicians; CareLocker, a patient-centric cloud architecture; and Feedback Connect that enables imaging-led point-of-care decision making in remote areas. The company was incorporated in 1958 and is based in London, the United Kingdom.
Feedback PLC management
10- Dr. Thomas James Oakley B.Sc.CEO & Director · born 1988
- Ms. Emma Jane StuartCFO & Director · born 1971
- Mr. Michael Peter HayballTechnical Director · born 1967
- Dr. Stephen BrownRegulatory & Compliance Director
- Richard DulcamaraHead of Sales
- Antoine SaillantHead of Product
- Thomas SpankieHead of Integration
- Ms. Carrie GoldsworthyHead of Marketing
- Ben EdrichHead of Engineering
- Mark FletcherManaging Director